JP2025016453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025016453A5 JP2025016453A5 JP2024169863A JP2024169863A JP2025016453A5 JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5 JP 2024169863 A JP2024169863 A JP 2024169863A JP 2024169863 A JP2024169863 A JP 2024169863A JP 2025016453 A5 JP2025016453 A5 JP 2025016453A5
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- formulation
- μbar
- lyophilized
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788916P | 2019-01-06 | 2019-01-06 | |
| US62/788,916 | 2019-01-06 | ||
| PCT/US2020/012202 WO2020142701A1 (en) | 2019-01-06 | 2020-01-03 | Collagenase formulations and methods of producing the same |
| JP2021539410A JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Division JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025016453A JP2025016453A (ja) | 2025-02-04 |
| JP2025016453A5 true JP2025016453A5 (https=) | 2025-04-25 |
Family
ID=69845512
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
| JP2024169863A Pending JP2025016453A (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20220305094A1 (https=) |
| EP (1) | EP3906014A1 (https=) |
| JP (2) | JP7565280B2 (https=) |
| KR (1) | KR20210113271A (https=) |
| CN (1) | CN113382714A (https=) |
| AU (2) | AU2020204922B2 (https=) |
| BR (1) | BR112021012675A2 (https=) |
| IL (2) | IL321891A (https=) |
| MX (1) | MX2021008017A (https=) |
| WO (1) | WO2020142701A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113025599B (zh) * | 2021-04-02 | 2023-09-12 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌i型胶原酶及其制备方法和应用 |
| CN112941058B (zh) * | 2021-04-02 | 2023-12-05 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用 |
| CN114264633B (zh) * | 2022-02-10 | 2022-09-06 | 上海蓝长科技集团有限公司 | 一种福尔马肼聚合物冻干粉及制备方法 |
| AU2023232693A1 (en) * | 2022-03-08 | 2024-09-19 | Connext Co.,Ltd. | Composition comprising collagenase, calcium, histidine, and glycine, and method for stabilizing collagenase |
| CN119656117B (zh) * | 2024-12-18 | 2025-08-29 | 远大生命科学(鞍山)有限公司 | 一种药物组合物及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2921180B1 (en) * | 1999-02-22 | 2019-08-14 | University of Connecticut | Albumin-free factor VIII formulations |
| US6440414B1 (en) * | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| CN101312744A (zh) | 2005-11-22 | 2008-11-26 | 惠氏公司 | 免疫球蛋白融合蛋白制剂 |
| US7811560B2 (en) | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| ES2388219T3 (es) * | 2008-06-02 | 2012-10-10 | F. Hoffmann-La Roche Ag | Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum |
| WO2012125948A1 (en) | 2011-03-16 | 2012-09-20 | Biospecifics Technologies Corp. | Compositions and methods for producing clostridial collagenases |
| JP2014530873A (ja) * | 2011-10-21 | 2014-11-20 | オーキシリウム インターナショナル ホールディングス，インコーポレイテッド | Ｅｆｐの治療または低減方法 |
| PT2802652T (pt) | 2012-01-12 | 2019-09-10 | Endo Global Ventures | Enzimas de clostridium histolyticum |
| EP3834840B8 (en) | 2013-03-15 | 2025-09-17 | Endo Biologics Limited | Treatment method and product for uterine fibroids using purified collagenase |
| US10137179B2 (en) * | 2016-05-18 | 2018-11-27 | Hyalo Technologies, LLC | Composition and method of preparation of protease microparticulate slow release preparation |
| CA3039655A1 (en) * | 2016-10-07 | 2018-04-12 | Regeneron Pharmaceuticals, Inc. | Room temperature stable lyophilized protein |
| EP4591945A3 (en) * | 2017-03-01 | 2026-04-15 | Endo Operations Limited | Apparatus and method for assessing and treating cellulite |
-
2020
- 2020-01-03 US US17/419,899 patent/US20220305094A1/en not_active Abandoned
- 2020-01-03 AU AU2020204922A patent/AU2020204922B2/en active Active
- 2020-01-03 WO PCT/US2020/012202 patent/WO2020142701A1/en not_active Ceased
- 2020-01-03 IL IL321891A patent/IL321891A/en unknown
- 2020-01-03 BR BR112021012675-9A patent/BR112021012675A2/pt active Search and Examination
- 2020-01-03 MX MX2021008017A patent/MX2021008017A/es unknown
- 2020-01-03 KR KR1020217024557A patent/KR20210113271A/ko not_active Ceased
- 2020-01-03 CN CN202080010875.3A patent/CN113382714A/zh active Pending
- 2020-01-03 JP JP2021539410A patent/JP7565280B2/ja active Active
- 2020-01-03 IL IL284270A patent/IL284270B2/en unknown
- 2020-01-03 EP EP20712071.8A patent/EP3906014A1/en active Pending
-
2023
- 2023-09-29 US US18/478,368 patent/US12303557B2/en active Active
-
2024
- 2024-09-30 JP JP2024169863A patent/JP2025016453A/ja active Pending
-
2025
- 2025-04-22 US US19/185,838 patent/US20250249080A1/en active Pending
- 2025-06-30 AU AU2025204915A patent/AU2025204915A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025016453A5 (https=) | ||
| Thakral et al. | Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations | |
| AU2018203556B2 (en) | Recombinant clostridium botulinum neurotoxins | |
| Toyoda et al. | Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus | |
| KR101744900B1 (ko) | 보툴리눔 독소를 포함하는 안정한 액상 조성물 | |
| EP2652131B1 (de) | Lagerstabiles flüssiges wasch- oder reinigungsmittel enthaltend protease und amylase | |
| WO2010146598A2 (en) | Stable, dried rotavirus vaccine, compositions and process for preparation thereof | |
| Izutsu et al. | Stabilizing effect of amphiphilic excipients on the freeze‐thawing and freeze‐drying of lactate dehydrogenase | |
| JP2010509226A5 (https=) | ||
| JP2021521159A5 (https=) | ||
| JP2003510369A (ja) | フィブリン溶解剤の薬剤組成物 | |
| CA2554018A1 (en) | Lyophilization method to improve excipient crystallization | |
| CN105985942A (zh) | 赖氨酰肽链内切酶冻干及贮存保护剂 | |
| CN114752703A (zh) | 一种新型冠状病毒核酸的冻干型检测试剂及其制备方法 | |
| US7101693B2 (en) | Plasticized hydrophilic glasses for improved stabilization of biological agents | |
| WO2019028976A1 (zh) | 耐热保护剂、猪瘟可室温保存活疫苗及其制备方法和应用 | |
| AU2022217094B2 (en) | Botulinum toxin freeze-dried dosage form composition storable for long time | |
| CN114317700A (zh) | 荧光pcr试剂冻干保护剂、冻干方法及应用 | |
| CN116209460A (zh) | 用于治疗或预防由冠状病毒引起的人或动物的病毒感染的菠萝蛋白酶、菠萝酶、木菠萝素类凝集素、来自菠萝植物茎和/或果的提取物、组合制剂、菠萝蛋白酶抑制剂、蛋白质-蛋白酶混合物和外源性非酶糖化产生的糖化菠萝酶蛋白 | |
| JP2022514942A (ja) | ペグアスパラガーゼの凍結乾燥組成物 | |
| CN117368453A (zh) | 心肌炎症复合质控品及其制备方法 | |
| EP4628092A8 (en) | Insulin aspart composition (embodiments) | |
| JPWO2022038281A5 (https=) | ||
| JPWO2022046651A5 (https=) | ||
| JPWO2022256359A5 (https=) |